🇺🇸 FDA
Patent

US 9512065

Polymorphs of N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride

granted A61PA61P1/04A61P1/18

Quick answer

US patent 9512065 (Polymorphs of N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride) held by KalVista Pharmaceuticals Limited expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KalVista Pharmaceuticals Limited
Grant date
Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/04, A61P1/18, A61P11/00, A61P13/12